SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-000719
Filing Date
2024-02-02
Accepted
2024-02-02 16:30:35
Documents
15
Period of Report
2024-01-31
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K gbio-20240131x8k.htm   iXBRL 8-K 32543
  Complete submission text file 0001558370-24-000719.txt   141916

Data Files

Seq Description Document Type Size
2 EX-101.SCH gbio-20240131.xsd EX-101.SCH 3940
3 EX-101.DEF gbio-20240131_def.xml EX-101.DEF 2734
4 EX-101.LAB gbio-20240131_lab.xml EX-101.LAB 12457
5 EX-101.PRE gbio-20240131_pre.xml EX-101.PRE 9527
16 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20240131x8k_htm.xml XML 4112
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

IRS No.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39319 | Film No.: 24591967
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)